These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32879763)

  • 1. DS-7080a, a Selective Anti-ROBO4 Antibody, Shows Anti-Angiogenic Efficacy with Distinctly Different Profiles from Anti-VEGF Agents.
    Isumi Y; Hayashi S; Inoue T; Yoshigae Y; Sato T; Hasegawa J; Agatsuma T
    Transl Vis Sci Technol; 2020 Aug; 9(9):7. PubMed ID: 32879763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice.
    Hu W; Cai W; Wu Y; Ren C; Yu D; Li T; Shen T; Xu D; Yu J
    Int J Nanomedicine; 2024; 19():35-51. PubMed ID: 38187905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
    Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
    Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2.
    Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J
    Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
    Balser C; Wolf A; Herb M; Langmann T
    J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.
    Tolentino MJ; Husain D; Theodosiadis P; Gragoudas ES; Connolly E; Kahn J; Cleland J; Adamis AP; Cuthbertson A; Miller JW
    Arch Ophthalmol; 2000 Jan; 118(1):78-84. PubMed ID: 10636419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys.
    Ji WW; Yu DA; Yang P; Fang P; Cao YX; Li H; Xie N; Yan SS
    Eur J Pharm Sci; 2017 Nov; 109():624-630. PubMed ID: 28916483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.
    Bailey C; Scott LJ; Rogers CA; Reeves BC; Hamill B; Peto T; Chakravarthy U; Harding SP;
    Ophthalmology; 2019 Jan; 126(1):75-86. PubMed ID: 30301555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model.
    Lin X; Wang Q; He M
    Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
    Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
    PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
    Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
    Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
    Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization.
    Toledano S; Lu H; Palacio A; Kigel B; Kessler O; Allon G; Barak Y; Neufeld G; Schaal S
    Exp Eye Res; 2016 Dec; 153():186-194. PubMed ID: 27725196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization.
    Abdel-Rahman MH; Yang Y; Salem MM; Meadows S; Massengill JB; Li PK; Davidorf FH
    Exp Eye Res; 2010 Dec; 91(6):837-43. PubMed ID: 21055400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.